Article ; Online: Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment.
Multiple sclerosis (Houndmills, Basingstoke, England)
2011 Volume 17, Issue 8, Page(s) 931–938
Abstract: Background: Neuropsychological studies have extensively described the presence of cognitive dysfunction in MS patients. One possible pharmacological treatment of the impairment could be based on acetylcholinesterase inhibitors (AChEIs), which have shown ...
Abstract | Background: Neuropsychological studies have extensively described the presence of cognitive dysfunction in MS patients. One possible pharmacological treatment of the impairment could be based on acetylcholinesterase inhibitors (AChEIs), which have shown efficacy in alleviating cognitive impairment in many other disorders. The findings on the efficacy of AChEI medication in MS associated cognitive symptoms are preliminary and no studies concerning cerebral acetylcholinesterase (AChE) activity in these patients have been published. Objective: The objective of the study was to examine cerebral AChE activity in cognitively deteriorated MS patients. Cerebral AChE activity of 10 MS patients with secondary progressive disease and marked cognitive impairment, and 10 healthy controls, was studied with positron emission tomography using tracer (11)C-MP4A. Methods: The cognitive profile of the patients was assessed with CERAD (Consortium to Establish a Registry for Alzheimer's Disease). Results: No differences in cortical AChE activity between MS patients and controls were seen. Conclusions: In the patient group regional AChE activities had inverse correlations with Word learning and MMSE (Mini-Mental State Examination) scores. In the group of cognitively deteriorated MS patients no change in cerebral AChE activity, compared with controls, was observed, but within the patient group more pronounced cognitive symptoms were associated with higher cerebral AChE activity. |
---|---|
MeSH term(s) | Acetylcholinesterase/metabolism ; Adult ; Cerebral Cortex/diagnostic imaging ; Cerebral Cortex/enzymology ; Cognition Disorders/diagnostic imaging ; Cognition Disorders/enzymology ; Cognition Disorders/etiology ; Female ; Humans ; Image Processing, Computer-Assisted ; Male ; Middle Aged ; Multiple Sclerosis/complications ; Multiple Sclerosis/diagnostic imaging ; Multiple Sclerosis/enzymology ; Neuropsychological Tests ; Positron-Emission Tomography |
Chemical Substances | Acetylcholinesterase (EC 3.1.1.7) |
Language | English |
Publishing date | 2011-08 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 1290669-4 |
ISSN | 1477-0970 ; 1352-4585 |
ISSN (online) | 1477-0970 |
ISSN | 1352-4585 |
DOI | 10.1177/1352458511399613 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4428: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.